Inflammation in prostate carcinogenesis

About 20% of all human cancers are caused by chronic infection or chronic inflammatory states. Recently, a new hypothesis has been proposed for prostate carcinogenesis. It proposes that exposure to environmental factors such as infectious agents and dietary carcinogens, and hormonal imbalances lead to injury of the prostate and to the development of chronic inflammation and regenerative 'risk factor' lesions, referred to as proliferative inflammatory atrophy (PIA). By developing new experimental animal models coupled with classical epidemiological studies, genetic epidemiological studies and molecular pathological approaches, we should be able to determine whether prostate cancer is driven by inflammation, and if so, to develop new strategies to prevent the disease.

[1]  J. Hicks,et al.  826: The Dietary Charred Meat Carcinogen 2-Amino-1-Methyl-6-Phenylimidazo[4,5-B]Pyridine (Phip) Acts as an Initiator and Tumor Promoter in the Rat Ventral Prostate , 2006 .

[2]  C. Janeway,et al.  Innate immune recognition. , 2002, Annual review of immunology.

[3]  R. Cardiff,et al.  Inflammation and atrophy precede prostatic neoplasia in a PhIP-induced rat model. , 2006, Neoplasia.

[4]  J. Bahm.  Prostate Cancer: Biology, Genetics, and the New Therapeutics , 2008 .

[5]  J. Fox,et al.  CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. , 2003, The American journal of pathology.

[6]  S. Akira,et al.  Cutting Edge: Role of Toll-Like Receptor 1 in Mediating Immune Response to Microbial Lipoproteins1 , 2002, The Journal of Immunology.

[7]  D. Hanahan,et al.  MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis , 2000, Cell.

[8]  L. Villarreal,et al.  Detection of human polyomaviruses and papillomaviruses in prostatic tissue reveals the prostate as a habitat for multiple viral infections , 2002, The Prostate.

[9]  P. Walsh.  A prospective study on the intake of animal products and risk of prostate cancer. , 2002, The Journal of urology.

[10]  John T. Wei,et al.  Sexual behavior, sexually transmitted diseases and prostatitis: the risk of prostate cancer in black men. , 2006, The Journal of urology.

[11]  A. Aprikian,et al.  Prostate cancer and use of nonsteroidal anti-inflammatory drugs: systematic review and meta-analysis , 2004, British Journal of Cancer.

[12]  G. Pihan,et al.  Centrosome abnormalities and chromosome instability occur together in pre-invasive carcinomas. , 2003, Cancer research.

[13]  A. D. De Marzo,et al.  The dietary charred meat carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine acts as both a tumor initiator and promoter in the rat ventral prostate. , 2007, Cancer research.

[14]  K. Holmes,et al.  Asymptomatic gonorrhea in men. Diagnosis, natural course, prevalence and significance. , 1974, The New England journal of medicine.

[15]  H. Grönberg,et al.  Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk , 2005, British Journal of Cancer.

[16]  D. S. Coffey.  Similarities of prostate and breast cancer: Evolution, diet, and estrogens. , 2001, Urology.

[17]  J. Emmett,et al.  THE INCIDENCE OF COINCIDENT PROSTATIC CALCULI, PROSTATIC HYPERPLASIA AND CARCINOMA OF THE PROSTATE GLAND , 1944 .

[18]  R. Kirby,et al.  Ki-67 expression in early prostate cancer and associated pathological lesions. , 1996, Journal of clinical pathology.

[19]  M. Knize,et al.  Formation and human risk of carcinogenic heterocyclic amines formed from natural precursors in meat. , 2005, Nutrition reviews.

[20]  T. Guthrie,et al.  Prostate cancer. , 2020, American family physician.

[21]  S. Gordon,et al.  A naturally occurring isoform of the human macrophage scavenger receptor (SR-A) gene generated by alternative splicing blocks modified LDL uptake. , 1998, Journal of lipid research.

[22]  S. Gordon,et al.  The Class A Macrophage Scavenger Receptor Attenuates CXC Chemokine Production and the Early Infiltration of Neutrophils in Sterile Peritonitis1 , 2004, The Journal of Immunology.

[23]  K. Aozasa,et al.  In situ shortening of CAG repeat length within the androgen receptor gene in prostatic cancer and its possible precursors , 2004, The Prostate.

[24]  J. McNeal,et al.  Normal histology of the prostate. , 1988, The American journal of surgical pathology.

[25]  I. M. Neiman,et al.  [Inflammation and cancer]. , 1974, Patologicheskaia fiziologiia i eksperimental'naia terapiia.

[26]  M. Shen,et al.  Mouse models of prostate carcinogenesis. , 2002, Trends in genetics : TIG.

[27]  W. Willett,et al.  Plasma Antibodies against Trichomonas vaginalis and Subsequent Risk of Prostate Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.

[28]  J. Cerhan,et al.  No association of germline alteration of MSR1 with prostate cancer risk , 2003, Nature Genetics.

[29]  R. Kirby,et al.  Intra-prostatic urinary reflux: an aetiological factor in abacterial prostatitis. , 1982, British journal of urology.

[30]  P. Figdor.  [PROSTATIC CALCULI]. , 1964, Zeitschrift fur Urologie.

[31]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[32]  L. Dennis,et al.  Meta-Analysis of Measures of Sexual Activity and Prostate Cancer , 2002, Epidemiology.

[33]  R. Montironi,et al.  Precancerous Lesions and Conditions of the Prostate , 2002 .

[34]  W. Willett,et al.  Gonorrhea, Syphilis, Clinical Prostatitis, and the Risk of Prostate Cancer , 2006, Cancer Epidemiology Biomarkers & Prevention.

[35]  A. Banham,et al.  CD4+CD25high T Cells Are Enriched in the Tumor and Peripheral Blood of Prostate Cancer Patients1 , 2006, The Journal of Immunology.

[36]  J. Crowley,et al.  Design of the Prostate Cancer Prevention Trial (PCPT). , 1995, Controlled clinical trials.

[37]  W. Gage,et al.  GSTA1 expression in normal, preneoplastic, and neoplastic human prostate tissue , 2001, The Prostate.

[38]  T. Mcclanahan,et al.  IL-23 promotes tumour incidence and growth , 2006, Nature.

[39]  E. Rimm,et al.  A prospective study of dietary fat and risk of prostate cancer. , 1993, Journal of the National Cancer Institute.

[40]  R. Silverman.  Implications for RNase L in prostate cancer biology. , 2003, Biochemistry.

[41]  H. Grönberg,et al.  Analysis of the macrophage scavenger receptor 1 gene in Swedish hereditary and sporadic prostate cancer , 2004, The Prostate.

[42]  L. True,et al.  Consensus development of a histopathological classification system for chronic prostatic inflammation , 2001, BJU international.

[43]  Theodore L DeWeese,et al.  Pathological and molecular mechanisms of prostate carcinogenesis: Implications for diagnosis, detection, prevention, and treatment , 2004, Journal of cellular biochemistry.

[44]  A. Jemal,et al.  Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.

[45]  W. Gage,et al.  Intermediate cells in human prostate epithelium are enriched in proliferative inflammatory atrophy. , 2003, The American journal of pathology.

[46]  G. Steiner,et al.  Expression and function of pro‐inflammatory interleukin IL‐17 and IL‐17 receptor in normal, benign hyperplastic, and malignant prostate , 2003, The Prostate.

[47]  J. McNeal,et al.  Propionibacterium acnes associated with inflammation in radical prostatectomy specimens: a possible link to cancer evolution? , 2005, The Journal of urology.

[48]  S. Devesa,et al.  International trends and patterns of prostate cancer incidence and mortality , 2000, International journal of cancer.

[49]  Stephen S. Sternberg,et al.  Histology for Pathologists , 1992, Annals of Internal Medicine.

[50]  A. Meeker,et al.  Telomeres and telomerase in prostatic intraepithelial neoplasia and prostate cancer biology. , 2006, Urologic oncology.

[51]  T. Rebbeck,et al.  Association of Susceptibility Alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with Prostate Cancer Severity in European American and African American Men , 2005, Cancer Epidemiology Biomarkers & Prevention.

[52]  E. Platz,et al.  Epidemiology of inflammation and prostate cancer. , 2004, The Journal of urology.

[53]  Michael J Thun,et al.  A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence. , 2005, Journal of the National Cancer Institute.

[54]  M. Toni,et al.  Isolation of Chlamydia trachomatis from the prostatic cells in patients affected by nonacute abacterial prostatitis. , 1985, The Journal of urology.

[55]  H. Kolb,et al.  Cutting Edge: Heat Shock Protein 60 Is a Putative Endogenous Ligand of the Toll-Like Receptor-4 Complex1 , 2000, The Journal of Immunology.

[56]  Donald E. Riley,et al.  Diverse and Related 16S rRNA-Encoding DNA Sequences in Prostate Tissues of Men with Chronic Prostatitis , 1998, Journal of Clinical Microbiology.

[57]  G. Kramer,et al.  Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[58]  E. Gelmann,et al.  Molecular biology of prostate-cancer pathogenesis , 2006, Current opinion in urology.

[59]  L. Dennis,et al.  Epidemiologic association between prostatitis and prostate cancer. , 2002, Urology.

[60]  N. Fleshner,et al.  An update on chemoprevention strategies in prostate cancer for 2006 , 2006, Current opinion in urology.

[61]  D. S. Coffey,et al.  Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells. , 1998, The American journal of pathology.

[62]  G. Ronquist,et al.  Evidence for a mechanistic association between nonbacterial prostatitis and levels of urate and creatinine in expressed prostatic secretion. , 1996, Journal of Urology.

[63]  Julian Peto,et al.  Cancer epidemiology in the last century and the next decade , 2001, Nature.

[64]  L. M. Franks.  Atrophy and hyperplasia in the prostate proper. , 1954, The Journal of pathology and bacteriology.

[65]  W. Isaacs,et al.  Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma. , 2001, Cancer Research.

[66]  J. Papadimitriou,et al.  Prostatic corpora amylacea and crystalloids: similarities and differences on ultrastructural and histochemical studies. , 1996, Journal of submicroscopic cytology and pathology.

[67]  F. Chisari,et al.  Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B. , 2000, The American journal of pathology.

[68]  J. Epstein,et al.  Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. , 1999, The American journal of pathology.

[69]  K. Aozasa,et al.  Postatrophic hyperplasia of the prostate in Japan: Histologic and immunohistochemical features and p53 gene mutation analysis , 2002, The Prostate.

[70]  G. Prins,et al.  The role of Fgf10 signaling in branching morphogenesis and gene expression of the rat prostate gland: lobe-specific suppression by neonatal estrogens. , 2005, Developmental biology.

[71]  Adam S. Kibel,et al.  A common variant associated with prostate cancer in European and African populations , 2007 .

[72]  J. Carpten,et al.  Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk , 2002, Nature Genetics.

[73]  R. Shah,et al.  Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander? , 2001, The American journal of pathology.

[74]  C. Sawyers,et al.  The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.

[75]  W. Isaacs,et al.  Molecular pathways to prostate cancer. , 2003, The Journal of urology.

[76]  David C. Miller,et al.  Germ-line mutations of the macrophage scavenger receptor 1 gene: association with prostate cancer risk in African-American men. , 2003, Cancer research.

[77]  M. Shen,et al.  Roles of the Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis , 2003, Developmental dynamics : an official publication of the American Association of Anatomists.

[78]  R. Ulevitch,et al.  Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. , 2001, Biochimica et biophysica acta.

[79]  J. Hicks,et al.  Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection. , 2003, The American journal of pathology.

[80]  F. Martinon,et al.  Gout-associated uric acid crystals activate the NALP3 inflammasome , 2006, Nature.

[81]  A. Rich.  On the frequency of occurrence of occult carcinoma of the prostate , 1979 .

[82]  W. Foulkes,et al.  The RNASEL 471delAAAG allele and prostate cancer in Ashkenazi Jewish men , 2003, Journal of medical genetics.

[83]  S. Abraham,et al.  Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α , 1996, Nature.

[84]  G. Bartsch,et al.  Assessment of aberrations on chromosome 8 in prostatic atrophy , 2006, BJU international.

[85]  S. Hernández-Díaz,et al.  The epidemiology of prostate cancer--with a focus on nonsteroidal anti-inflammatory drugs. , 2006, Hematology/oncology clinics of North America.

[86]  John Condeelis,et al.  Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis , 2006, Cell.

[87]  G. Kramer,et al.  Cytokine Expression Pattern in Benign Prostatic Hyperplasia Infiltrating T Cells and Impact of Lymphocytic Infiltration on Cytokine mRNA Profile in Prostatic Tissue , 2003, Laboratory Investigation.

[88]  A. De Marzo,et al.  Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia. , 2000, Urology.

[89]  R. Alexander,et al.  PSA is a candidate self‐antigen in autoimmune chronic prostatitis/chronic pelvic pain syndrome , 2000, The Prostate.

[90]  D. S. Coffey,et al.  The role of androgens and estrogens in the pathogenesis of experimental nonbacterial prostatitis. , 1988, The Journal of urology.

[91]  R. Eeles,et al.  Influence of cytokine gene polymorphisms on the development of prostate cancer. , 2002, Cancer research.

[92]  W. A. Gardner,et al.  Trichomonas vaginalis in the prostate gland. , 1986, Archives of pathology & laboratory medicine.

[93]  W C Willett,et al.  The causes and prevention of cancer. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[94]  E. Meares.  Infection stones of prostate gland. Laboratory diagnosis and clinical management. , 1974, Urology.

[95]  H. Grönberg,et al.  Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study. , 2004, Cancer research.

[96]  J. Derisi,et al.  Identification of a Novel Gammaretrovirus in Prostate Tumors of Patients Homozygous for R462Q RNASEL Variant , 2006, PLoS pathogens.

[97]  J. Pollard,et al.  Distinct role of macrophages in different tumor microenvironments. , 2006, Cancer research.

[98]  J. Groopman,et al.  Role of metabolism and viruses in aflatoxin-induced liver cancer. , 2005, Toxicology and applied pharmacology.

[99]  E. Metter,et al.  Nonsteroidal Anti-inflammatory Drugs and Risk of Prostate Cancer in the Baltimore Longitudinal Study of Aging , 2005, Cancer Epidemiology Biomarkers & Prevention.

[100]  J. Epstein,et al.  Histology and cellular kinetics of prostatic atrophy. , 1998, The American journal of surgical pathology.

[101]  J. Isaacs.  Prostatic structure and function in relation to the etiology of prostatic cancer , 1983, The Prostate.

[102]  T. Sugimura,et al.  Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish , 2004, Cancer science.

[103]  Z. Hall.  Cancer , 1906, The Hospital.

[104]  J. Schleutker,et al.  Germ-line alterations in MSR1 gene and prostate cancer risk. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[105]  D A Meyers,et al.  Major Susceptibility Locus for Prostate Cancer on Chromosome 1 Suggested by a Genome-Wide Search , 1996, Science.

[106]  Jianfeng Xu,et al.  Meta‐analysis of association of rare mutations and common sequence variants in the MSR1 gene and prostate cancer risk , 2006, The Prostate.

[107]  T. Kodama,et al.  Macrophage scavenger receptor down-regulates mycobacterial cord factor-induced proinflammatory cytokine production by alveolar and hepatic macrophages. , 2006, Microbial pathogenesis.

[108]  I. McInnes,et al.  TNF-blocking therapies: an alternative mode of action? , 2005, Trends in immunology.

[109]  R. Silverman,et al.  A dominant negative mutant of 2‐5A‐dependent RNase suppresses antiproliferative and antiviral effects of interferon. , 1993, The EMBO journal.

[110]  R. Montironi,et al.  Precancerous lesions and conditions of the prostate: from morphological and biological characterization to chemoprevention. , 2002, Annals of the New York Academy of Sciences.

[111]  A. Whittemore,et al.  Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men , 2006, Proceedings of the National Academy of Sciences.

[112]  G. Klunder.  Gonorrhea in the Male and Female , 1934 .

[113]  B. Williams,et al.  A transcriptional signaling pathway in the IFN system mediated by 2'-5'-oligoadenylate activation of RNase L. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[114]  J. Carpten,et al.  A comprehensive association study for genes in inflammation pathway provides support for their roles in prostate cancer risk in the CAPS study , 2006, The Prostate.

[115]  Pär Stattin,et al.  H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer. , 2004, Journal of the National Cancer Institute.

[116]  K. Murphy,et al.  Th17: an effector CD4 T cell lineage with regulatory T cell ties. , 2006, Immunity.

[117]  A. Aderem,et al.  Cutting Edge: Functional Interactions Between Toll-Like Receptor (TLR) 2 and TLR1 or TLR6 in Response to Phenol-Soluble Modulin1 , 2001, The Journal of Immunology.

[118]  D. English,et al.  Macrophage Scavenger Receptor 1 999C>T (R293X) Mutation and Risk of Prostate Cancer , 2005, Cancer Epidemiology Biomarkers & Prevention.

[119]  T. Stamey,et al.  Zonal Distribution of Prostatic Adenocarcinoma: Correlation with Histologic Pattern and Direction of Spread , 1988, The American journal of surgical pathology.

[120]  J. Macoska,et al.  8p22 loss concurrent with 8c gain is associated with poor outcome in prostate cancer. , 2000, Urology.

[121]  Yanping,et al.  Loss of the Cyclin-dependent Kinase Inhibitor 27Kq Protein in Human Prostate Cancer Correlates with Tumor Grade’ , 2005 .

[122]  L. Coussens,et al.  Paradoxical roles of the immune system during cancer development , 2006, Nature Reviews Cancer.

[123]  W. Willett,et al.  Ejaculation frequency and subsequent risk of prostate cancer. , 2004, JAMA.

[124]  C. Bieberich,et al.  Decreased NKX3.1 Protein Expression in Focal Prostatic Atrophy, Prostatic Intraepithelial Neoplasia, and Adenocarcinoma: Association with Gleason Score and Chromosome 8p Deletion , 2006 .

[125]  Daniel B. Martin,et al.  Tumorigenesis and Neoplastic Progression Regulation of Hepatocyte Activator Inhibitor-1 Expression by Androgen and Oncogenic Transformation in the Prostate , 2005 .

[126]  S. Akira,et al.  Discrimination of bacterial lipoproteins by Toll-like receptor 6. , 2001, International immunology.

[127]  Steven F Dowdy,et al.  Cip/Kip proteins: more than just CDKs inhibitors. , 2004, Genes & development.

[128]  C. Maier,et al.  Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene , 2005, British Journal of Cancer.

[129]  A. Reiss,et al.  Syndrome , 1990, Biological Psychiatry.

[130]  J. Goedert,et al.  Sexual behavior and evidence for an infectious cause of prostate cancer. , 2001, Epidemiologic reviews.

[131]  B. Wells,et al.  Prostate cancer and sexually transmitted diseases: a meta-analysis. , 2005, Family medicine.

[132]  Daniel J Schaid,et al.  The complex genetic epidemiology of prostate cancer. , 2004, Human molecular genetics.

[133]  R. Hayes,et al.  Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer. , 2006, Cancer research.

[134]  R. Weinstein,et al.  Pathology and Pathobiology of the Urinary Bladder and Prostate , 1992 .

[135]  D. Bostwick,et al.  Intraepithelial and stromal lymphocytes in the normal human prostate , 2003, The Prostate.

[136]  G. Kramer,et al.  The picture of the prostatic lymphokine network is becoming increasingly complex. , 2002, Reviews in urology.

[137]  S. Cole,et al.  Sexually transmitted infections and prostatic inflammation/cell damage as measured by serum prostate specific antigen concentration. , 2006, The Journal of urology.

[138]  H. Grönberg,et al.  Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk. , 2005, Journal of the National Cancer Institute.

[139]  D. Hunter,et al.  Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer. , 2005, Cancer research.

[140]  D. Wilson.  Tissue , 2009, The Lancet.

[141]  G. Prins,et al.  Estrogenic regulation of signaling pathways and homeobox genes during rat prostate development. , 2004, Journal of andrology.

[142]  David G. Bostwick,et al.  Urologic Surgical Pathology , 1997 .

[143]  G. Prins,et al.  The role of prolactin in the prostatic inflammatory response to neonatal estrogen. , 2003, Endocrinology.

[144]  L R Ferguson,et al.  Heterocyclic amine content of cooked meat and risk of prostate cancer. , 1999, Journal of the National Cancer Institute.

[145]  E. Bleecker,et al.  Common sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. , 2003, American journal of human genetics.

[146]  F. Garcia,et al.  Intraprostatic spermatozoa: zonal distribution and association with atrophy. , 2006, Human pathology.

[147]  T. DeWeese,et al.  Loss-of-function of Nkx3.1 promotes increased oxidative damage in prostate carcinogenesis. , 2005, Cancer research.

[148]  B. Katzenellenbogen,et al.  Estrogen Imprinting of the Developing Prostate Gland Is Mediated through Stromal Estrogen Receptor α Studies with αERKO and βERKO Mice , 2001 .

[149]  T. Kodama,et al.  The Class A Macrophage Scavenger Receptor Is a Major Pattern Recognition Receptor for Neisseria meningitidis Which Is Independent of Lipopolysaccharide and Not Required for Secretory Responses , 2002, Infection and Immunity.

[150]  S. Akira,et al.  TIR domain-containing adaptors define the specificity of TLR signaling. , 2004, Molecular immunology.

[151]  M. Loda,et al.  Low p27 expression predicts poor disease-free survival in patients with prostate cancer. , 1998, The Journal of urology.

[152]  Rich Ar.  On The Frequency of Occurrence of Occult Carcinoma of the Prostate1 , 1935 .

[153]  C. Cobbs,et al.  High prevalence of human cytomegalovirus in prostatic intraepithelial neoplasia and prostatic carcinoma. , 2003, The Journal of urology.

[154]  H. Grönberg,et al.  Genetic Analysis of the RNASEL Gene in Hereditary, Familial, and Sporadic Prostate Cancer , 2004, Clinical Cancer Research.

[155]  E. Meares.  Laboratory Diagnosis and Clinical Management , 1974 .

[156]  S. Kasper.  Survey of genetically engineered mouse models for prostate cancer: Analyzing the molecular basis of prostate cancer development, progression, and metastasis , 2005, Journal of cellular biochemistry.

[157]  G. Dranoff,et al.  Cytokines in cancer pathogenesis and cancer therapy , 2004, Nature Reviews Cancer.

[158]  P. Härkönen,et al.  Role of estrogens in development of prostate cancer , 2004, The Journal of Steroid Biochemistry and Molecular Biology.